Skip to main content
Top

Current Colorectal Cancer Reports

Issue 1/2013

Content (11 Articles)

Prevention and Early Detection (N Arber, Section Editor)

Tipping the Balance: Benefits and Risks of Aspirin in Chemoprevention of Colorectal Cancer

Prarthana Thiagarajan, Janusz A. Jankowski

Prevention and Early Detection (N Arber, Section Editor)

Is There Enough Evidence for Aspirin in High-Risk Groups?

Peter C. Elwood, Maribel Almonte, Mohammed Mustafa

Prevention and Early Detection (N Arber, Section Editor)

Screening for Colorectal Cancer: When, how, and by Whom?

Jochim S. Terhaar sive Droste, Elisabeth Macken, Marc A. Peeters

Prevention and Early Detection (N Arber, Section Editor)

The Optimal Staging of Rectal Cancer

Ravit Geva, Arye Blachar, Hagit Tulchinsky

Prevention and Early Detection (N Arber, Section Editor)

Probiotics in the Prevention of Colorectal Cancer

Haim Shmuely, Noam Domniz, Dani Cohen

Prevention and Early Detection (N Arber, Section Editor)

Prevention and Treatment of Colorectal Cancer by Natural Agents from Mother Nature

Bharat Aggarwal, Sahdeo Prasad, Bokyung Sung, Sunil Krishnan, Sushovan Guha

Personalized Medicine in Colorectal Cancer (CMS Rocha-Lima, Section Editor)

BRAF, KRAS, and Phosphatidylinositol 3-Kinase in the Management of Metastatic Colorectal Cancer

Anelisa K. Coutinho, Gabriel Prolla, Rui Weschenfelder

Personalized Medicine in Colorectal Cancer (CMS Rocha-Lima, Section Editor)

Colon Cancer Liver Metastasis: Addition of Antiangiogenesis or EGFR Inhibitors to Chemotherapy

Marcelo R. S. Cruz, Gilberto de Lima Lopes

Personalized Medicine in Colorectal Cancer (CMS Rocha-Lima, Section Editor)

Newer Agents in Colon Cancer: What’s Next?

Belisario A. Arango, Ikechukwu Akunyili

Molecular Epidemiology (L Jiao, Section Editor)

Blood Biomarkers Linked to Oxidative Stress and Chronic Inflammation for Risk Assessment of Colorectal Neoplasia

Francesca Maffei, Sabrina Angelini, Giorgio Cantelli Forti, Patrizia Hrelia

Molecular Epidemiology (L Jiao, Section Editor)

Intestinal Microbes, Diet, and Colorectal Cancer

Kishore Vipperla, Stephen J. O’Keefe

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine